An individualized cirrhosis screening strategy might be more cost-effective in the general population

J Hepatol. 2022 Dec;77(6):1728-1729. doi: 10.1016/j.jhep.2022.06.035. Epub 2022 Jul 16.
No abstract available

Keywords: Chronic liver disease; Cirrhosis; Noninvasive.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / diagnosis
  • Cost-Benefit Analysis
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Neoplasms* / diagnosis
  • Mass Screening